arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 10/2013 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Discussion on measles vaccination

    NEW ON THE MARKET

    Tiotropium solution (SPIRIVA RESPIMAT) - safety trial published

    a-t READERS' QUESTIONS AND COMMENTS

    On treatment duration with bisphosphonates for osteoporosis

    Aldosterone antagonist eplerenone (INSPRA): second-line therapy in chronic cardiac failure

    Opioid substitution: further alternatives needed

    Continuing medical education: certification obtained by devious means

    IN BRIEF

    Perioperative new prescription of beta-blocker for cardiac prevention in non-cardiac surgery

    Obsessive-compulsive disorders: augmentation with behavioural therapy is effective, augmentation with risperidone (RISPERDAL, generics) is not effective

    Rotavirus vaccination and breastfeeding

    Japan: investigation against Novartis on manipulated valsartan (DIOVAN) trials

    CURRENT ADR NETWORK REPORT

    Ventricular fibrillation with pregabalin (LYRICA)

    e a-t IN INTERNET

    Alemtuzumab (LEMTRADA) for the treatment of multiple sclerosis is 29.000 times more expensive than gold
    free

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles